Author:
Makanga Michael,Beattie Pauline,Jajkowicz Dominika,Nyirenda Thomas,Tanner Marcel,Hankins Catherine
Funder
European and Developing Countries Clinical Trials Partnership
Reference7 articles.
1. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial;Datoo;Lancet,2021
2. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial;Datoo;Lancet Infect Dis,2022
3. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis;N Engl J Med,2022
4. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV,2022
5. Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial;N'Goran;Lancet Infect Dis,2023